Based on currently available information, the company provided guidance for full year 2025 revenues before reimbursable expenses in a range of $1.58B-$1.66B, consensus $1.6B. The company also anticipates adjusted EBITDA as a percentage of revenues before reimbursable expenses in a range of 14.0% to 14.5%, and adjusted diluted EPS guidance in a range of $6.80 to $7.60.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HURN:
